Effect of GLP1R agonists taspoglutide and liraglutide on primary thyroid C-cells from rodent and man

Journal of Molecular Endocrinology

Volumn 50, Issue 3, 2013, Pages 325-336

  Boess, Franziska ^a   Bertinetti Lapatki, Cristina ^a   Zoffmann, Sannah ^a   George, Catherine ^b   Pfister, Thomas ^a   Roth, Adrian ^a   Lee, Serene M L ^c   Thasler, Wolfgang E ^b   Singer, Thomas ^a   Suter, Laura ^d  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b IPSEN   (France)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF APPLIED SCIENCES AND ARTS NORTHWESTERN SWITZERLAND   (Switzerland)

Author keywords

C cell; Glp1 receptor; Human; Liraglutide; Primary cultures; Rodent; Taspoglutide

Indexed keywords

BIM 51282; CALCITONIN; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; LIOTHYRONINE; LIRAGLUTIDE; MESSENGER RNA; RO 5073031 001; TASPOGLUTIDE; UNCLASSIFIED DRUG; WAA 490 63 61;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIOTHYRONINE SYNTHESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID GLAND;

EID: 84876168934     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-12-0186     Document Type: Article

References (32)

1. Bjerre Knudsen L, Madsen LW, Andersen S, Almholt K, de Boer AS, Drucker DJ, Gotfredsen C, Egerod FL, Hegelund AC, Jacobsen H et al. 2010 Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Endocrinology 151 1473-1486. (doi:10.1210/en.2009-1272)
2. Brubaker PL & Drucker DJ 2004 Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145 2653-2659. (doi:10.1210/en. 2004-0015)
3. Bullock BP, Heller RS & Habener JF 1996 Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137 2968-2978. (doi:10.1210/en.137.7.2968)
4. Capen CC 2008 Toxic responses of the endocrine system. In Caserett and Doull's Toxicology, 7th edn, Ed. CD Klassen. The Basic Science of Poisons. McGraw-Hill.
5. Chiu WY, Shih SR & Tseng CH 2012 A review on the association between glucagon-like peptide-1 receptor agonists and thyroid cancer. Experimental Diabetes Research 2012 924168. (doi:10.1155/2012/ 924168)
6. Clark MS, Lanigan TM, Page NM & Russo AF 1995 Induction of a serotonergic and neuronal phenotype in thyroid C-cells. Journal of Neuroscience 15 6167-6178.
7. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M et al. 2007 Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. Journal of Clinical Endocrinology and Metabolism 92 450-455. (doi:10.1210/jc.2006-1590)
8. Crespel A, De Boisvilliers F, Gros L & Kervran A 1996 Effects of glucagon and glucagon-like peptide-1-(7-36) amide on C cells from rat thyroid and medullary thyroid carcinoma CA-77 cell line. Endocrinology 137 3674-3680. (doi:10.1210/en.137.9.3674)
9. Doyle ME & Egan JM 2007 Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacology & Therapeutics 113 546-593. (doi:10.1016/j.pharmthera.2006.11.007)
10. EMA 2006 European Medicines Agency (EMA) 2006: Assessment report for Byetta http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000698/WC500051842.pdf.
11. EMA 2009 European Medicines Agency (EMA) 2009: Assessment report for Victoza http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001026/WC500050016.pdf.
12. EMA 2011 European Medicines Agency (EMA) 2011: Assessment report for Bydureon http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002020/WC500108239.pdf.
13. Endo T, Saito T, Uchida T & Onaya T 1988 Effects of somatostatin and serotonin on calcitonin secretion from cultured rat parafollicular cells. Acta Endocrinologica 117 214-218.
14. Feinstein RE, Westergren E, Bucht E, Sjoberg HE & Grimelius L 1996 Estimation of the C-cell numbers in rat thyroid glands using the optical fractionator. Journal of Histochemistry and Cytochemistry 44 997-1003. (doi:10.1177/44.9.8773565)
15. Gier B, Butler PC, Lai CK, Kirakossian D, DeNicola MM & Yeh MW 2012 Glucagon like peptide-1 receptor expression in the human thyroid gland. Journal of Clinical Endocrinology and Metabolism 97 121-131. (doi:10.1210/jc.2011-2407)
16. Gmuender R, Okamoto E & Hedinger C 1983 Verteilung der C-Zellen in menschlichen Schliddruesen. Schweizerische Medizinische Wochenschrift 113 1385.
17. Lu CC, Tsai SC, Huang WJ, Tsai CL & Wang PS 1999 Effects of hyperprolactinemia on calcitonin secretion in male rats. Metabolism 48 221-226. (doi:10.1016/S0026-0495(99)90038-0)
18. Madsen LW, Knauf JA, Gotfredsen C, Pilling A, Sjogren I, Andersen S, Andersen L, Sietske de Boer A, Manova K, Barlas A et al. 2012 GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation. Endocrinology 153 1538-1547. (doi:10.1210/en.2011-1864)
19. Moerch U, Nielsen HS, Lundsgaard D & Oleksiewicz MB 2007 Flow sorting from organ material by intracellular markers. Cytometry. Part A: the Journal of the International Society for Analytical Cytology 71 495-500. (doi:10.1002/cyto.a.20418)
20. Mu JY 1976 The effect of TSH on 131Imetabolism by human thyroid in vitro. Chinese Journal of Physiology 20 157-167.
21. Nishiyama I & Fujii T 1989 Somatostatin-immunoreactive C-cells in primary cultures of fetal, neonatal and young rat thyroid glands. Biomedical Research 10 353-359.
22. Nystrom T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahren B & Sjoholm A 2004 Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. American Journal of Physiology. Endocrinology and Metabolism 287 E1209-E1215. (doi:10.1152/ajpendo.00237.2004)
23. Parks M & Rosebraugh C 2010 Weighing risks and benefits of liraglutide - the FDA's review of a new antidiabetic therapy. New England Journal of Medicine 362 774-777. (doi:10.1056/NEJMp1001578)
24. Parola T 2009 Endocrinologic and Metabolic Drugs Advisory Committee Meeting, Victozaw (liraglutide injection): Human Relevance of Rodent Thyroid C-cell Tumors ppt-slide presentation of April 2, 2009. http://www.fda.gov/downloads/UCM151129.pdf.
25. Pilling AM, Jones SA, Endersby-Wood HJ, McCormack NA & Turton JA 2007 Expression of thyroglobulin and calcitonin in spontaneous thyroid gland tumors in the Han Wistar rat. Toxicologic Pathology 35 348-355. (doi:10.1080/01926230701230270)
26. Sebokova E, Christ AD, Wang H, Sewing S, Dong JZ, Taylor J, Cawthorne MA & Culler MD 2010 Taspoglutide, an analog of human glucagon-like peptide-1 with enhanced stability and in vivo potency. Endocrinology 151 2474-2482. (doi:10.1210/en.2009-1459)
27. Toda S, Aoki S, Uchihashi K, Matsunobu A, Yamamoto M, Ootani A, Yamasaki F, Koike E & Sugihara H 2011 Culture models for studying thyroid biology and disorders. ISRN Endocrinology 2011 275782. (doi:10.5402/2011/275782)
28. Vickers AE, Heale J, Sinclair JR, Morris S, Rowe JM & Fisher RL 2012 Thyroid organotypic rat and human cultures used to investigate drug effects on thyroid function, hormone synthesis and release pathways. Toxicology and Applied Pharmacology 260 81-88. (doi:10.1016/j.taap. 2012.01.029)
29. Waser B, Beetschen K, Pellegata NS & Reubi JC 2011 Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: relevance for incretin-based diabetes therapy. Neuroendocrinology 94 291-301. (doi:10.1159/000330447)
30. Wolfe HJ, Voelkel EF & Tashjian AH Jr 1974 Distribution of calcitonin-containing cells in the normal adult human thyroid gland: a correlation of morphology with peptide content. Journal of Clinical Endocrinology and Metabolism 38 688-694. (doi:10.1210/jcem- 38-4-688)
31. Yamamoto M, Takizawa T, Arishima K & Eguchi Y 1986 Differentiation and thyroid-stimulating hormone (TSH) sensitivity of the fetal rat thyroid in organ culture. Anatomical Record 215 361-364. (doi:10.1002/ar. 1092150405)
32. Zerek-Melen G, Lewinski A & Szkudlinski M 1990 Influence of somatostatin and epidermal growth factor (EGF) on the proliferation of thyroid follicular cells in organ culture. Regulatory Peptides 28 293-300. (doi:10.1016/0167-0115(90)90027-T)